30 April 2025 in Traumatology and Orthopаedics of Kazakhstan
Анкилозирующий спондилоартрит является серьезным хроническим воспалительным заболеванием, вызывающим значительные изменения в биомеханике позвоночника и уменьшение его сопротивляемости. Патологический процесс включает в себя окостенение связок, анкилоз позвоночных суставов, развитие остеопороза и последующую деформацию позвоночника. Оценивается, что относительный риск переломов позвоночника при анкилозирующем спондилоартрите в 3 раза выше, чем в среднем по миру. Около 14% пациентов испытывают переломы на протяжении своей жизни. В случаях, когда медикаментозная терапия оказывается недостаточно эффективной или когда деформации вызывают существенные функциональные нарушения и ухудшение качества жизни, может потребоваться хирургическое вмешательство. Хроническое воспаление и формирование костных спондилов между позвонками снижают гибкость позвоночника, что в свою очередь, повышает риск переломов даже при минимальных травмах. Переломы часто оказываются нестабильными и требуеют надлежащего лечения для предотвращения первичных и вторичных неврологических повреждений, инвалидности и прогрессирующей деформации позвоночника. В рассматриваемом клиническом случае нестабильность позвоночно-двигательного сегмента привела к нарушению проводимости спинного мозга, что потребовало тщательного и обоснованного подхода к выбору хирургической тактики. Анкилозирующий спондилоартрит вносит значительные коррективы в структуру и функцию позвоночника, что может привести к серьезным последствиям. Это подчеркивает важность своевременного хирургического вмешательства и экстренной помощи для предотвращения тяжелых осложнений.
28 February 2026 in Traumatology and Orthopаedics of Kazakhstan
Spinal fusion is one of the most common methods of treating spinal injuries, but despite improvements in implant designs, the incidence of pseudoarthrosis remains high. In this regard, there is growing interest in cell technologies aimed at enhancing osteogenesis. A literature search was conducted in the PubMed, Web of Science, and Google Scholar databases for the period 2016 - 2025. The analysis included clinical studies, systematic reviews, and meta-analyses on the use of cell technologies in spondylodesis of the thoracic and lumbar spine. The review examines the use of mesenchymal stromal cells, bone marrow aspirate, stromal - vascular fraction, bone morphogenetic proteins, bioactive peptides, and autologous growth factors. Analysis of the literature shows that the use of cell technologies contributes to the enhancement of regenerative processes in spinal fusion and improves clinical treatment outcomes. Cell technologies represent a promising direction for improving the effectiveness of spinal fusion. Further research should focus on standardising application protocols and studying long-term treatment outcomes.
28 October 2025 in Traumatology and Orthopаedics of Kazakhstan
This study aimed to evaluate clinical and radiological outcomes of lumbar interbody fusion using a titanium cage filled with autologous stromal vascular fraction of adipose tissue in degenerative lumbar spine disease.Thirty patients with degenerative lumbar spine disease unresponsive to conservative treatment underwent posterior or transforaminal lumbar interbody fusion with decompression, transpedicular fixation and implantation of a porous titanium interbody cage packed with autologous bone and a cell based biocomposite hydrogel containing stromal vascular fraction of adipose tissue. Pain in the lumbar region and lower limbs was assessed with a visual analogue scale, and disability with the Oswestry Disability Index before surgery and at one, three to four and twelve months after surgery. Radiological evaluation included radiography, computed tomography densitometry of the interbody region and grading of fusion according to the Tan classification at twelve months.No intraoperative neurological or implant related complications occurred, and wound healing was uneventful. During twelve months of follow up there was a marked reduction in lumbar and leg pain and disability, with most patients improving from severe to minimal functional impairment. Computed tomography showed a progressive increase in bone density in the cage region, indicating maturation of the interbody bone block. At twelve months, complete interbody fusion was achieved in seventy per cent of patients, partial fusion in twenty per cent and monopolar pseudarthrosis in ten per cent; no bipolar pseudarthrosis was observed. Lumbar interbody fusion using a porous titanium cage combined with autologous stromal vascular fraction of adipose tissue provided reliable stabilization, a high rate of fusion and clinically meaningful improvement in pain and function during the first postoperative year.
2 April 2026 in Orthopedic Reviews
Background: Degenerative lumbar spinal stenosis is a leading cause of disability, and lumbar interbody fusion (LIF) is a common surgical option. However, pseudarthrosis and suboptimal fusion remain important limitations. Porous titanium cages with biologically active hydrogels may enhance osteointegration compared with PEEK implants. Methods: This single-centre prospective randomized trial included 50 patients with lumbar stenosis undergoing single-level TLIF. Patients were allocated 1:1 to Group I (trabecular Ti-6Al-4V cage with autologous bone and stromal-vascular fraction–based heparin-conjugated fibrin hydrogel) or Group II (PEEK cage with autologous bone only). Follow-up was 12 months. Primary endpoints were CT-based fusion at 12 months (Tan classification) and bone density within the cage region (Hounsfield units, HU). Secondary outcomes included pain (VAS), disability (ODI), implant subsidence/migration, operative parameters, and complications. Results: Baseline demographic and clinical characteristics and intraoperative blood loss were comparable between groups. Mean HU values were significantly higher in Group I at 3–4, 6 and 12 months (428.0±68.6 vs 388.8±46.6, p=0.0228; 527.5±81.8 vs 466.4±52.7, p=0.0031; 594.8±78.7 vs 521.0±75.0, p=0.0014). Complete fusion (Tan grade 1) at 12 months was achieved in 68% of Group I versus 32% of Group II patients (p=0.0227). Group I also showed greater VAS and ODI improvement at all postoperative time points. No intraoperative complications or hydrogel-related adverse events were observed. Conclusions: A trabecular titanium cage combined with autologous bone and SVF-based hydrogel appears safe and more effective than a PEEK cage with autograft, providing superior radiological fusion and faster recovery at 12 months